Qualigen Therapeutics Inc logo

Qualigen Therapeutics Inc (QLGN) live share price

Qualigen Therapeutics Inc share price in USD $4.69 & INR ₹397.22

$4.69

0.07

(1.58%)

View live Qualigen Therapeutics Inc share price in Dollar and Rupees. Guide to invest in Qualigen Therapeutics Inc from India. Also see the sentimental analysis on Indian investors investing in Qualigen Therapeutics Inc. Get details on the Indian mutual funds that are investing in Qualigen Therapeutics Inc. Get Analyst recommendations and forecasts along with all the Qualigen Therapeutics Inc's financials.

Qualigen Therapeutics Inc share price movements

  • $4.38
    $4.71

    Day's Volatility :6.91%

  • $3.34
    $37.45

    52 Weeks Volatility :91.09%

Qualigen Therapeutics Inc Returns

PeriodQualigen Therapeutics IncIndex (Russel 2000)
3 Months
-50.51%
0.0%
6 Months
-65.8%
0.0%
1 Year
-86.82%
0.0%
3 Years
-99.22%
-19.8%

Qualigen Therapeutics Inc Key Statistics

in dollars & INR

Market Capitalization
$3.4M
Revenue TTM
$5.0M
EBITDA
$-8.3M
Earnings Per Share (EPS)
$3635.0
PE Ratio
0.0
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-841.66%

How to invest in Qualigen Therapeutics Inc from India?

It is very easy for Indian residents to invest directly in Qualigen Therapeutics Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Qualigen Therapeutics Inc stock in both rupees (INR) and dollars (USD). Search for Qualigen Therapeutics Inc or QLGN on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Qualigen Therapeutics Inc or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Qualigen Therapeutics Inc shares which would translate to 0.181 fractional shares of Qualigen Therapeutics Inc as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Qualigen Therapeutics Inc

-48%

Period: Sep 3, 2024 to Dec 2, 2024. Change in 30 Days versus previous period

Search volume for Qualigen Therapeutics Inc on INDmoney from India has reduced in the last 30 days as on Dec 3, 2024. -48% less investors are searching Qualigen Therapeutics Inc in the last 30 days versus the previous period.

Global Institutional Holdings in Qualigen Therapeutics Inc

  • UBS Group AG

    0.19%

  • Geode Capital Management, LLC

    0.08%

  • BlackRock Inc

    0.07%

  • XTX Topco Ltd

    0.06%

  • Vanguard Group Inc

    0.06%

  • Virtu Financial LLC

    0.06%

Analyst Recommendation on Qualigen Therapeutics Inc

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Qualigen Therapeutics Inc(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Qualigen Therapeutics Inc

What analysts predicted

Upside of 6.61%

Current:

$4.69

Target:

$5.00

Insights on Qualigen Therapeutics Inc

  • Increasing Revenue

    Revenue is up for the last 3 quarters, 1.38M → 7.94M (in $), with an average increase of 47.0% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -1.57M → -1.79M (in $), with an average decrease of 13.8% per quarter
  • Vs ALNY

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 47.6% return, outperforming this stock by 135.0%
  • Vs VRTX

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 38.4% return, outperforming this stock by 137.7%

Qualigen Therapeutics Inc Technicals Summary

Sell

Neutral

Buy

Qualigen Therapeutics Inc is currently in a neutral trading position according to technical analysis indicators.

Qualigen Therapeutics Inc Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Qualigen Therapeutics Inc
-8.66%
-65.8%
-86.82%
-99.22%
-99.88%
Regeneron Pharmaceuticals, Inc.
-9.49%
-24.47%
-8.88%
20.04%
103.68%
Biontech Se
8.64%
19.01%
18.5%
-57.69%
426.41%
Alnylam Pharmaceuticals, Inc.
-6.25%
68.98%
46.39%
42.98%
103.71%
Vertex Pharmaceuticals Incorporated
-0.99%
-1.44%
33.51%
128.29%
109.86%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Qualigen Therapeutics Inc
0.0
0.0
NA
0.0
-8.42
-0.75
NA
-19.61
Regeneron Pharmaceuticals, Inc.
18.55
18.66
1.12
44.91
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.06
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.22
0.54
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Qualigen Therapeutics Inc
Buy
$3.4M
-99.88%
0.0
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$83.0B
103.68%
18.55
33.61%
Biontech Se
Buy
$28.9B
426.41%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$32.7B
103.71%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$120.6B
109.86%
32.84
-4.51%

About Qualigen Therapeutics Inc

Organization
Qualigen Therapeutics Inc
Employees
4
CEO
Mr. Michael S. Poirier
Industry
Health Technology

Important FAQs about investing in Qualigen Therapeutics Inc from India :

What is Qualigen Therapeutics Inc share price today?

Qualigen Therapeutics Inc (QLGN) share price today is $4.69.

Can Indians buy Qualigen Therapeutics Inc shares?

Yes, Indians can invest in the Qualigen Therapeutics Inc (QLGN) from India.

With INDmoney, you can buy Qualigen Therapeutics Inc at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Qualigen Therapeutics Inc at zero transaction cost.

How can I buy Qualigen Therapeutics Inc shares from India?

It is very easy to buy Qualigen Therapeutics Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Qualigen Therapeutics Inc be purchased?

Yes, you can buy fractional shares of Qualigen Therapeutics Inc with INDmoney app.

What are the documents required to start investing in Qualigen Therapeutics Inc stocks?

To start investing in Qualigen Therapeutics Inc, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Qualigen Therapeutics Inc

Today’s highest price of Qualigen Therapeutics Inc (QLGN) is $4.71.

Today’s lowest price of Qualigen Therapeutics Inc (QLGN) is $4.38.

What is today's market capitalisation of Qualigen Therapeutics Inc

Today's market capitalisation of Qualigen Therapeutics Inc QLGN is 3.4M

What is the 52 Week High and Low Range of Qualigen Therapeutics Inc

  • 52 Week High

    $37.45

  • 52 Week Low

    $3.34

How much percentage Qualigen Therapeutics Inc is down from its 52 Week High?

Qualigen Therapeutics Inc (QLGN) share price is $4.69. It is down by 99% from its 52 Week High price of $37.45.

How much percentage Qualigen Therapeutics Inc is up from its 52 Week low?

Qualigen Therapeutics Inc (QLGN) share price is $4.69. It is up by 1% from its 52 Week Low price of $3.34.

What are the historical returns of Qualigen Therapeutics Inc?

  • 1 Month Returns

    -8.66%

  • 3 Months Returns

    -65.8%

  • 1 Year Returns

    -86.82%

  • 5 Years Returns

    -99.88%

Who is the Chief Executive Officer (CEO) of Qualigen Therapeutics Inc

Mr. Michael S. Poirier is the current Chief Executive Officer (CEO) of Qualigen Therapeutics Inc.